IND submitted to FDA for Eledon-sponsored, registrational study of tegoprubart in islet cell transplantation for patients with type 1 diabetes First patients enrolled in new investigator-initiated ...
An investigational antibody could reduce the toxicity associated with immune suppression in islet cell transplantation for type 1 diabetes (T1D), according to new preliminary data. Six people with T1D ...
ZyVersa Therapeutics (ZVSA) highlights data from an article published in the peer-reviewed International Journal of Nanomedicine titled Small Intestinal Endocrine Cell Derived Exosomal ACE2 Protects ...
A comprehensive study that integrates multiple analytic approaches has linked a regulatory gene network and functional defects in insulin-producing pancreatic beta cells to type 2 diabetes. The study, ...
A joint effort involving research teams from Vanderbilt University Medical Center (VUMC) and the University of Michigan has linked the activities of a regulatory gene network and functional defects in ...
Type 2 diabetes (T2DM) is a systematic multi-organ metabolic disease, which is characterized by dynamic interplay among different organs. Pancreatic islet-liver axis is closely associated with normal ...
Long-term Western diet impairs islet blood vessel function and insulin transport even after diet reversal and weight loss, according to a new study from researchers at Karolinska Institutet. A new ...
Dynamic SMOC1 expression across differentiation supports a developmental function distinct from its association with adult T2D β-cell dysfunction and dedifferentiation signatures. SMOC1 knockout ...
IRVINE, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE)-- Eledon Pharmaceuticals, Inc. ("Eledon") (Nasdaq: ELDN) today announced significant progress across multiple tegoprubart development programs in kidney ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results